Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Healthcare Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Sernova Corp
Bullboard Posts
User Avatar Image
(168)
•••
Post by jwalliscaon Jun 18, 2020 6:25pm
162 Views
Post# 31167035

Level II Close suggested thinness

Level II Close suggested thinness
The Level II snapshot is interesting as it showed SVA was thin to 28 cents. The 500 share single board lot offering at 28 cents is a computer come on suggesting the Algorithms are hanging round.
 
We got lucky that we went back up and not on many shares (just 14.5k TSXV [the exchange that counts], but some 24k Alternate exchanges), i.e. "thin" no matter how you call it. Note the 153 share oddlot signal at 3:19 pm.
 
jwall
 
Last 25 TSXV Trades:
 
 
Number of Shares Bid Price
 
26,500 shares		 26,500 0.275
 
10,000 shares		 10,000 0.265
 
40,000 shares		 40,000 0.260
 
14,000 shares		 14,000 0.255
 
91,000 shares		 91,000 0.250
 
10,500 shares		 10,500 0.240
 
20,000 shares		 20,000 0.230
 
3,000 shares		 3,000 0.225
 
2,000 shares		 2,000 0.220
 
27,500 shares		 27,500 0.215
Level two quotes - Ask
Ask Price Number of Shares
0.280 500
 
500 shares
0.290 56,500
 
56,500 shares
0.295 62,500
 
62,500 shares
0.300 49,000
 
49,000 shares
0.305 10,000
 
10,000 shares
0.310 32,500
 
32,500 shares
0.315 11,000
 
11,000 shares
0.320 89,000
 
89,000 shares
0.325 40,000
 
40,000 shares
0.330 4,000
 
 

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities